메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한정신약물학회 Clinical Psychopharmacology and Neuroscience Clinical Psychopharmacology and Neuroscience 제8권 제2호
발행연도
2010.1
수록면
111 - 114 (4page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Delirium is common in hospitalized patients, and the gold standard for the control of its symptoms is haloperidol. Haloperidol,however, has some adverse effects, including extrapyramidal symptoms, which require limiting its use. Many studies have reported on the effectiveness of atypical antipsychotics such as aripiprazole, risperidone, olanzapine, and quetiapine for delirium,all of which have been found to be safe and effective alternatives to haloperidol. To our knowledge, only two reports have described the use of ziprasidone for treating delirium; such reports may be rare for several reasons, but the most likely one concerns its adverse effects. Although ziprasidone has the potential to cause dose-related QTc interval prolongation and is considered more likely to do so than several other antipsychotics, clinically significant prolongation of the QTc interval (generally defined as >500 ms) with recommended dosages of ziprasidone has been uncommon. Generally, checking the electrocardiogram regularly in patients without heart disease who take ziprasidone is thought to be unnecessary. We herein describe some patients with delirium who were treated with ziprasidone. A low rate of adverse effects was observed, and thus ziprasidone may be an appropriate for the treatment of delirium. A controlled comparison study should be performed to confirm this finding.

목차

등록된 정보가 없습니다.

참고문헌 (22)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0